These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 35025797)

  • 21. Functional imaging of neuroendocrine tumors with combined PET/CT using 68Ga-DOTATATE (DOTA-DPhe1,Tyr3-octreotate) and 18F-FDG.
    Kayani I; Bomanji JB; Groves A; Conway G; Gacinovic S; Win T; Dickson J; Caplin M; Ell PJ
    Cancer; 2008 Jun; 112(11):2447-55. PubMed ID: 18383518
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of Leflunomide Use on 68Ga-DOTATATE Biodistribution in a Case With Neuroendocrine Tumor.
    Tatar G; Beyhan E; Arslan E; Ergül N; Çermik TF
    Clin Nucl Med; 2023 Feb; 48(2):e71-e73. PubMed ID: 36607376
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Can complementary 68Ga-DOTATATE and 18F-FDG PET/CT establish the missing link between histopathology and therapeutic approach in gastroenteropancreatic neuroendocrine tumors?
    Has Simsek D; Kuyumcu S; Turkmen C; Sanlı Y; Aykan F; Unal S; Adalet I
    J Nucl Med; 2014 Nov; 55(11):1811-7. PubMed ID: 25315243
    [TBL] [Abstract][Full Text] [Related]  

  • 24. False-Positive Uptake in Splenic Hemangioma on 68 Ga-DOTATATE PET/CT.
    Zhu B; Yoon E; Mahajan S; Kranz AO
    Clin Nucl Med; 2023 Jun; 48(6):518-519. PubMed ID: 37075248
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hibernoma Demonstrated on 68Ga-DOTATATE PET/CT.
    Woodford H; Le K; Bui C; Mansberg R
    Clin Nucl Med; 2019 Jun; 44(6):491-493. PubMed ID: 30932985
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Head-to-Head Comparison of
    Zhu W; Cheng Y; Wang X; Yao S; Bai C; Zhao H; Jia R; Xu J; Huo L
    J Nucl Med; 2020 Jun; 61(6):897-903. PubMed ID: 31676731
    [No Abstract]   [Full Text] [Related]  

  • 27. A comparison of 68Ga-DOTATATE and 18F-FDG PET/CT in pulmonary neuroendocrine tumors.
    Kayani I; Conry BG; Groves AM; Win T; Dickson J; Caplin M; Bomanji JB
    J Nucl Med; 2009 Dec; 50(12):1927-32. PubMed ID: 19910422
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Combined Interpretation of 68Ga-DOTATATE PET/CT and 18F-FDG PET/CT in Metastatic Gastroenteropancreatic Neuroendocrine Tumors: A Classification System With Prognostic Impact.
    Hayes AR; Furtado O'Mahony L; Quigley AM; Gnanasegaran G; Caplin ME; Navalkissoor S; Toumpanakis C
    Clin Nucl Med; 2022 Jan; 47(1):26-35. PubMed ID: 34874347
    [TBL] [Abstract][Full Text] [Related]  

  • 29. 68Ga-DOTATATE PET/CT imaging for insulinoma in MEN1 patient with endogenous hyperinsulinemic hypoglycemia: A case report.
    Liu Y; Zhao X; Zhang J; Wang J; Zhang Z; Dai M; Wang N; Jing F; Wang T; Tian W
    Medicine (Baltimore); 2022 Aug; 101(34):e30252. PubMed ID: 36042606
    [TBL] [Abstract][Full Text] [Related]  

  • 30. MIB-1 Index-Stratified Assessment of Dual-Tracer PET/CT with
    Sampathirao N; Basu S
    J Nucl Med Technol; 2017 Mar; 45(1):34-41. PubMed ID: 28154019
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A Rare Case of Pituitary Carcinoma With Bone Metastases: 68Ga-DOTATATE PET/CT Findings.
    Filizoglu N; Ozguven S
    Clin Nucl Med; 2022 Mar; 47(3):e298-e299. PubMed ID: 35025796
    [TBL] [Abstract][Full Text] [Related]  

  • 32. 18F-FDG PET/CT and 68Ga-DOTATATE PET/CT Findings in a Patient With Primary Renal Well-Differentiated Neuroendocrine Tumor.
    Şahin R; Baykal Koca S; Yücetaş U; Çermik TF; Ergül N
    Clin Nucl Med; 2022 Jul; 47(7):e503-e505. PubMed ID: 35384913
    [TBL] [Abstract][Full Text] [Related]  

  • 33. 68Ga-DOTATATE PET/CT Uptake in Prostate With an Incidental Finding of Prostatic Acinar Adenocarcinoma and Metastatic Neuroendocrine Cancer to the Liver.
    Nisar MU; Costa DN; Jia L; Öz OK; de Blanche L
    Clin Nucl Med; 2021 Aug; 46(8):e428-e430. PubMed ID: 34034323
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A Case of Brown Tumor on 68Ga-DOTATATE PET/CT and 18F-FDG PET/CT.
    Yao X; Ou X
    Clin Nucl Med; 2022 Jan; 47(1):88-89. PubMed ID: 34874352
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The Impact of 68Ga-DOTATATE PET/CT Imaging on Management of Patients with Neuroendocrine Tumors: Experience from a National Referral Center in the United Kingdom.
    Skoura E; Michopoulou S; Mohmaduvesh M; Panagiotidis E; Al Harbi M; Toumpanakis C; Almukhailed O; Kayani I; Syed R; Navalkissoor S; Ell PJ; Caplin ME; Bomanji J
    J Nucl Med; 2016 Jan; 57(1):34-40. PubMed ID: 26471695
    [TBL] [Abstract][Full Text] [Related]  

  • 36. 68Ga-DOTATATE PET/CT Distinguishes Neuroendocrine Tumor Mesenteric Lymph Node Metastasis From an Extensive IgG4-Positive Fibrosis Surrounding It.
    Ahmadi Bidakhvidi N; Cuyle PJ; Sagaert X; Ballaux F; Deroose CM
    Clin Nucl Med; 2021 Oct; 46(10):e510-e512. PubMed ID: 34034320
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Gastroenteropancreatic Neuroendocrine Tumor Diagnosis: DOTATATE PET/CT.
    Kandathil A; Subramaniam RM
    PET Clin; 2023 Apr; 18(2):189-200. PubMed ID: 36585339
    [TBL] [Abstract][Full Text] [Related]  

  • 38. 68Ga-DOTATOC versus 68Ga-DOTATATE PET/CT in functional imaging of neuroendocrine tumors.
    Poeppel TD; Binse I; Petersenn S; Lahner H; Schott M; Antoch G; Brandau W; Bockisch A; Boy C
    J Nucl Med; 2011 Dec; 52(12):1864-70. PubMed ID: 22072704
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Primary Neuroendocrine Tumor of the Ileostomy Stoma on 68Ga-DOTATATE PET/CT.
    Yu L; Braun A; Hansen NJ; Downey RT; Johnson CM
    Clin Nucl Med; 2020 Jun; 45(6):463-464. PubMed ID: 32366787
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Recurrent Glomus Jugulare Tumor Invading the Cerebellum on 68Ga-DOTATATE PET/CT.
    Balaban Genc ZC; Filizoglu N; Ozguven S
    Clin Nucl Med; 2022 May; 47(5):e406-e407. PubMed ID: 35261358
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.